The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder
The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings ( n = 236). T...
Gespeichert in:
Veröffentlicht in: | Molecular psychiatry 1999-11, Vol.4 (6), p.580-586 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 586 |
---|---|
container_issue | 6 |
container_start_page | 580 |
container_title | Molecular psychiatry |
container_volume | 4 |
creator | Rowe, D C Van den Oord, E J C G Stever, C Giedinghagen, L N Gard, J M C Cleveland, H H Gilson, M Terris, S T Mohr, J H Sherman, S Abramowitz, A Waldman, I D |
description | The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings (
n
= 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h
2
= 1.62% and 0.79%, respectively). Furthermore, a
genotype relative risk
test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the
A1
allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood. |
doi_str_mv | 10.1038/sj.mp.4000567 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69333900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2645752023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2717-9dd97869930cba7e3db423670dab7aea07afeaae2a9693919f4132a64a3c8e5e3</originalsourceid><addsrcrecordid>eNpt0Mlr3DAUB2BRGpqlPfZaBC25earVso4l6RIIBNLpWbyR5I4Gy3IkT8H_fTTMQErpSYL3vYUfQu8pWVHCu89lt4rTShBCZKteoQsqVNtIqbrX9c-lbgTtxDm6LGVHyKEo36BzSipggl6gn-utx7ePtwyv4ekOT2lYYsrTNpSIYXS4LHGaUyw49Rjm2Y9zSCN2vg82zHi7TD6DncOfMC_YhZKy8_ktOuthKP7d6b1Cv759Xd_8aO4fvt_dfLlvLFNUNdo5rbpWa07sBpTnbiMYbxVxsFHggSjoPYBnoFvNNdW9oJxBK4DbzkvPr9D1ce6U09Pel9nEUKwfBhh92hdTuzjXhFT48R-4S_s81tsMa4VUkhHGq2qOyuZUSva9mXKIkBdDiTlkbcrOxMmcsq7-w2nqfhO9-0sfw63g0wlAsTD0GUYbyoujHefysHd1ZKVWxt8-v1z3_8XP2PaWlQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2645752023</pqid></control><display><type>article</type><title>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Rowe, D C ; Van den Oord, E J C G ; Stever, C ; Giedinghagen, L N ; Gard, J M C ; Cleveland, H H ; Gilson, M ; Terris, S T ; Mohr, J H ; Sherman, S ; Abramowitz, A ; Waldman, I D</creator><creatorcontrib>Rowe, D C ; Van den Oord, E J C G ; Stever, C ; Giedinghagen, L N ; Gard, J M C ; Cleveland, H H ; Gilson, M ; Terris, S T ; Mohr, J H ; Sherman, S ; Abramowitz, A ; Waldman, I D</creatorcontrib><description>The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings (
n
= 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h
2
= 1.62% and 0.79%, respectively). Furthermore, a
genotype relative risk
test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the
A1
allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.</description><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/sj.mp.4000567</identifier><identifier>PMID: 10578241</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adolescent ; Adult ; Alleles ; Attention Deficit Disorder with Hyperactivity - genetics ; Attention deficit disorders. Hyperactivity ; Attention deficit hyperactivity disorder ; Behavioral Sciences ; Biological and medical sciences ; Biological Psychology ; Brain Chemistry - genetics ; Child ; Child clinical studies ; Children ; Dopamine D2 receptors ; Family Health ; Female ; Gene polymorphism ; Genetic Linkage ; Genotype ; Heritability ; Humans ; Hyperactivity ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; Neurosciences ; original-research-article ; Pharmacotherapy ; Polymorphism ; Polymorphism, Genetic ; Population genetics ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Receptors, Dopamine D2 - genetics ; Siblings ; Statistical analysis ; Taq Polymerase</subject><ispartof>Molecular psychiatry, 1999-11, Vol.4 (6), p.580-586</ispartof><rights>Macmillan Publishers Limited 1999</rights><rights>2000 INIST-CNRS</rights><rights>Macmillan Publishers Limited 1999.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2717-9dd97869930cba7e3db423670dab7aea07afeaae2a9693919f4132a64a3c8e5e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.mp.4000567$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.mp.4000567$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27904,27905,41468,42537,51299</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1183353$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10578241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rowe, D C</creatorcontrib><creatorcontrib>Van den Oord, E J C G</creatorcontrib><creatorcontrib>Stever, C</creatorcontrib><creatorcontrib>Giedinghagen, L N</creatorcontrib><creatorcontrib>Gard, J M C</creatorcontrib><creatorcontrib>Cleveland, H H</creatorcontrib><creatorcontrib>Gilson, M</creatorcontrib><creatorcontrib>Terris, S T</creatorcontrib><creatorcontrib>Mohr, J H</creatorcontrib><creatorcontrib>Sherman, S</creatorcontrib><creatorcontrib>Abramowitz, A</creatorcontrib><creatorcontrib>Waldman, I D</creatorcontrib><title>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><description>The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings (
n
= 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h
2
= 1.62% and 0.79%, respectively). Furthermore, a
genotype relative risk
test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the
A1
allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Alleles</subject><subject>Attention Deficit Disorder with Hyperactivity - genetics</subject><subject>Attention deficit disorders. Hyperactivity</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Behavioral Sciences</subject><subject>Biological and medical sciences</subject><subject>Biological Psychology</subject><subject>Brain Chemistry - genetics</subject><subject>Child</subject><subject>Child clinical studies</subject><subject>Children</subject><subject>Dopamine D2 receptors</subject><subject>Family Health</subject><subject>Female</subject><subject>Gene polymorphism</subject><subject>Genetic Linkage</subject><subject>Genotype</subject><subject>Heritability</subject><subject>Humans</subject><subject>Hyperactivity</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neurosciences</subject><subject>original-research-article</subject><subject>Pharmacotherapy</subject><subject>Polymorphism</subject><subject>Polymorphism, Genetic</subject><subject>Population genetics</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Siblings</subject><subject>Statistical analysis</subject><subject>Taq Polymerase</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0Mlr3DAUB2BRGpqlPfZaBC25earVso4l6RIIBNLpWbyR5I4Gy3IkT8H_fTTMQErpSYL3vYUfQu8pWVHCu89lt4rTShBCZKteoQsqVNtIqbrX9c-lbgTtxDm6LGVHyKEo36BzSipggl6gn-utx7ePtwyv4ekOT2lYYsrTNpSIYXS4LHGaUyw49Rjm2Y9zSCN2vg82zHi7TD6DncOfMC_YhZKy8_ktOuthKP7d6b1Cv759Xd_8aO4fvt_dfLlvLFNUNdo5rbpWa07sBpTnbiMYbxVxsFHggSjoPYBnoFvNNdW9oJxBK4DbzkvPr9D1ce6U09Pel9nEUKwfBhh92hdTuzjXhFT48R-4S_s81tsMa4VUkhHGq2qOyuZUSva9mXKIkBdDiTlkbcrOxMmcsq7-w2nqfhO9-0sfw63g0wlAsTD0GUYbyoujHefysHd1ZKVWxt8-v1z3_8XP2PaWlQ</recordid><startdate>19991101</startdate><enddate>19991101</enddate><creator>Rowe, D C</creator><creator>Van den Oord, E J C G</creator><creator>Stever, C</creator><creator>Giedinghagen, L N</creator><creator>Gard, J M C</creator><creator>Cleveland, H H</creator><creator>Gilson, M</creator><creator>Terris, S T</creator><creator>Mohr, J H</creator><creator>Sherman, S</creator><creator>Abramowitz, A</creator><creator>Waldman, I D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>19991101</creationdate><title>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</title><author>Rowe, D C ; Van den Oord, E J C G ; Stever, C ; Giedinghagen, L N ; Gard, J M C ; Cleveland, H H ; Gilson, M ; Terris, S T ; Mohr, J H ; Sherman, S ; Abramowitz, A ; Waldman, I D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2717-9dd97869930cba7e3db423670dab7aea07afeaae2a9693919f4132a64a3c8e5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Alleles</topic><topic>Attention Deficit Disorder with Hyperactivity - genetics</topic><topic>Attention deficit disorders. Hyperactivity</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Behavioral Sciences</topic><topic>Biological and medical sciences</topic><topic>Biological Psychology</topic><topic>Brain Chemistry - genetics</topic><topic>Child</topic><topic>Child clinical studies</topic><topic>Children</topic><topic>Dopamine D2 receptors</topic><topic>Family Health</topic><topic>Female</topic><topic>Gene polymorphism</topic><topic>Genetic Linkage</topic><topic>Genotype</topic><topic>Heritability</topic><topic>Humans</topic><topic>Hyperactivity</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neurosciences</topic><topic>original-research-article</topic><topic>Pharmacotherapy</topic><topic>Polymorphism</topic><topic>Polymorphism, Genetic</topic><topic>Population genetics</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Siblings</topic><topic>Statistical analysis</topic><topic>Taq Polymerase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rowe, D C</creatorcontrib><creatorcontrib>Van den Oord, E J C G</creatorcontrib><creatorcontrib>Stever, C</creatorcontrib><creatorcontrib>Giedinghagen, L N</creatorcontrib><creatorcontrib>Gard, J M C</creatorcontrib><creatorcontrib>Cleveland, H H</creatorcontrib><creatorcontrib>Gilson, M</creatorcontrib><creatorcontrib>Terris, S T</creatorcontrib><creatorcontrib>Mohr, J H</creatorcontrib><creatorcontrib>Sherman, S</creatorcontrib><creatorcontrib>Abramowitz, A</creatorcontrib><creatorcontrib>Waldman, I D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rowe, D C</au><au>Van den Oord, E J C G</au><au>Stever, C</au><au>Giedinghagen, L N</au><au>Gard, J M C</au><au>Cleveland, H H</au><au>Gilson, M</au><au>Terris, S T</au><au>Mohr, J H</au><au>Sherman, S</au><au>Abramowitz, A</au><au>Waldman, I D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>1999-11-01</date><risdate>1999</risdate><volume>4</volume><issue>6</issue><spage>580</spage><epage>586</epage><pages>580-586</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><abstract>The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings (
n
= 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h
2
= 1.62% and 0.79%, respectively). Furthermore, a
genotype relative risk
test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the
A1
allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>10578241</pmid><doi>10.1038/sj.mp.4000567</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1359-4184 |
ispartof | Molecular psychiatry, 1999-11, Vol.4 (6), p.580-586 |
issn | 1359-4184 1476-5578 |
language | eng |
recordid | cdi_proquest_miscellaneous_69333900 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Adolescent Adult Alleles Attention Deficit Disorder with Hyperactivity - genetics Attention deficit disorders. Hyperactivity Attention deficit hyperactivity disorder Behavioral Sciences Biological and medical sciences Biological Psychology Brain Chemistry - genetics Child Child clinical studies Children Dopamine D2 receptors Family Health Female Gene polymorphism Genetic Linkage Genotype Heritability Humans Hyperactivity Male Medical sciences Medicine Medicine & Public Health Neurosciences original-research-article Pharmacotherapy Polymorphism Polymorphism, Genetic Population genetics Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Receptors, Dopamine D2 - genetics Siblings Statistical analysis Taq Polymerase |
title | The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A07%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20DRD2%20TaqI%20polymorphism%20and%20symptoms%20of%20attention%20deficit%20hyperactivity%20disorder&rft.jtitle=Molecular%20psychiatry&rft.au=Rowe,%20D%20C&rft.date=1999-11-01&rft.volume=4&rft.issue=6&rft.spage=580&rft.epage=586&rft.pages=580-586&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/sj.mp.4000567&rft_dat=%3Cproquest_cross%3E2645752023%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2645752023&rft_id=info:pmid/10578241&rfr_iscdi=true |